TABLE 3.
Outcome | Active smokers¶ (n=5787) | Ex-smokers (n=8941) | Never-smokers (n=312) | ||||
Hazard ratio | 95% CI | p-value | Hazard ratio | 95% CI | p-value | ||
Time to death (from any cause) | |||||||
Univariate | 1.00 | 1.31 | 1.19–1.43 | <0.001 | 1.48 | 1.11–1.97 | 0.008 |
Adjusted# | 1.00 | 0.78 | 0.70–0.87 | <0.001 | 0.72 | 0.53–0.99 | 0.039 |
Time to first respiratory cause admission | |||||||
Univariate | 1.00 | 1.03 | 0.95–1.12 | 0.486 | 0.97 | 0.73–1.28 | 0.826 |
Adjusted# | 1.00 | 0.82 | 0.74–0.89 | <0.001 | 0.79 | 0.59–1.06 | 0.113 |
Time to first respiratory cause ED attendance | |||||||
Univariate | 1.00 | 0.83 | 0.74–0.92 | <0.001 | 0.63 | 0.41–0.98 | 0.038 |
Adjusted# | 1.00 | 0.78 | 0.70–0.88 | <0.001 | 0.71 | 0.45–1.11 | 0.130 |
#: the analysis was adjusted for: age, gender, body mass index, index of multiple deprivation rank decile, forced expiratory volume in 1 s % pred, presence of comorbidities (anxiety/depression, asthma, bronchiectasis, cerebrovascular disease, chronic kidney disease, connective tissue disease, dementia, diabetes mellitus, gastro-oesophageal reflux, heart failure, hyperlipidaemia, hypertension, ischaemic heart disease, lung cancer, obstructive sleep apnoea, osteoporosis, peripheral vascular disease, rhino-sinusitis) and inhaled medication at baseline (long-acting β₂-agonist, long-acting antimuscarinic bronchodilator, inhaled corticosteroid). Multiple imputation was used in the adjusted analysis, as described in the methods section. ¶: reference category.